XML 21 R5.htm IDEA: XBRL DOCUMENT v3.26.1
CONSOLIDATED STATEMENT OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Ordinary shares - Class A
Ordinary shares - Class B
Ordinary shares
Ordinary shares - Class A
Ordinary shares
Ordinary shares - Class B
Additional
Paid-in
Capital
Accumulated Deficit
Balance at beginning of period (in shares) at Dec. 31, 2022       8,135,348 2,780,570    
Balance at beginning of period at Dec. 31, 2022 $ 175,409     $ 0 $ 0 $ 897,337 $ (721,928)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of Ordinary shares, net (in shares)       91,802      
Issuance of Ordinary shares, net 467         467  
Exercise of options, warrants and vesting of RSUs (in shares)       225,110      
Exercise of options, warrants and vesting of RSUs 129         129  
Conversion of convertible note           3,104  
Share-based compensation 16,278         16,278  
Net loss (114,208)           (114,208)
Balance at end of period (in shares) at Dec. 31, 2023       8,452,260 2,780,570    
Balance at end of period at Dec. 31, 2023 78,075     $ 0 $ 0 914,211 (836,136)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of Ordinary shares, net (in shares)       9,973,752      
Issuance of Ordinary shares, net 45,535         45,535  
Exercise of options, warrants and vesting of RSUs (in shares)       980,085      
Exercise of options, warrants and vesting of RSUs 13         13  
Conversion of convertible note (in shares)       72,780      
Conversion of convertible note 550         550  
Share-based compensation 10,709         10,709  
Net loss (111,754)           (111,754)
Balance at end of period (in shares) at Dec. 31, 2024   19,478,877 2,780,570 19,478,877 2,780,570    
Balance at end of period at Dec. 31, 2024 23,128     $ 0 $ 0 971,018 (947,890)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of Ordinary shares, net (in shares)       8,595,807      
Issuance of Ordinary shares, net 34,361         34,361  
Exercise of options, warrants and vesting of RSUs (in shares)       669,230      
Exercise of options, warrants and vesting of RSUs 1         1  
Share-based compensation 5,067         5,067  
Net loss (55,807)           (55,807)
Balance at end of period (in shares) at Dec. 31, 2025   28,743,914 2,780,570 28,743,914 2,780,570    
Balance at end of period at Dec. 31, 2025 $ 6,750     $ 0 $ 0 $ 1,010,447 $ (1,003,697)